Predicting recurrent glioblastoma clinical outcome to immune checkpoint inhibition and low-dose bevacizumab with tumor in situ fluid circulating tumor DNA analysis
Article in Cancer Immunology, Immunotherapy (August 2024)
The most recent citing publication is shown below. View this citation on Dimensions.
Article in Cancer Immunology, Immunotherapy (August 2024)